×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:

2110 Total Publications

Improved longitudinal [18F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction
Brendel, M., Högenauer, M., Delker, A., Sauerbeck, J., Bartenstein, P., Seibyl, J., & Rominger, A.
PMID: 25482269 ; 2015; Journal Neuroimage; vol. 108; pp. 450-459; doi:10.1016/j.neuroimage.2014.11.055
Feature Selection Based on the SVM Weight Vector for Classification of Dementia
Bron, E., Smits, M., Niessen, W., & Klein, S.
PMID: 25974958 ; 2015; Journal IEEE Journal of Biomedical and Health Informatics; vol. 19; no. 5; pp. 1617-1626; doi:10.1109/JBHI.2015.2432832
Variations in the FRA10AC1 Fragile Site and 15q21 Are Associated with Cerebrospinal Fluid Aβ1-42 Level
Li, Q. S., Parrado, A. R., Samtani, M. N., & Narayan, V. A.
PMID: 26252872 ; PMCID:4529186 ; 2015; Journal PloS One; vol. 10; no. 8; pp. e0134000; doi:10.1371/journal.pone.0134000
Alzheimer risk genes modulate the relationship between plasma apoE and cortical PiB binding
Lazaris A, Hwang KS, Goukasian N, Ramirez LM, Eastman J, Blanken AE, Teng E, Gylys K, Cole G, Saykin AJ, Shaw LM, Trojanowski JQ, Jagust WJ, Weiner MW, Apostolova LG,.
PMID: 27066559 ; PMCID:4809461 ; 2015; Journal Neurology: Genetics; vol. 1; no. 3; pp. e22; doi:10.1212/NXG.0000000000000022
Tract-Based Analysis of White Matter Degeneration in Alzheimer’s Disease
Lee, S.-H., Coutu, J.-P., Wilkens, P., Yendiki, A., Rosas, H. D., & Salat, D. H.
PMID: 26026680 ; PMCID:4505932 ; 2015; Journal Neuroscience; vol. 301; pp. 79-89; doi:10.1016/j.neuroscience.2015.05.049
Identifying amyloid pathology–related cerebrospinal fluid biomarkers for Alzheimer’s disease in a multicohort study
Leung YY1, Toledo JB2, Nefedov A3, Polikar R4, Raghavan N5, Xie SX6, Farnum M7, Schultz T7, Baek Y2, Deerlin VV2, Hu WT8, Holtzman DM9, Fagan AM9, Perrin RJ10, Grossman M11, Soares HD12, Kling MA13, Mailman M7, Arnold SE14, Narayan VA7, Lee VM2, Shaw LM2, Baker D7, Wittenberg GM14, Trojanowski JQ2, Wang LS1
PMID: 26693175 ; PMCID:4672388 ; 2015; Journal Alzheimers Dementia; vol. 1; no. 3; pp. 339-348; doi:10.1016/j.dadm.2015.06.008
Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer’s disease
McIntyre, J. A., Ramsey, C. J., Gitter, B. D., Saykin, A. J., Wagenknecht, D. R., & Hyslop, P. A.
PMID: 25672931 ; PMCID:4490126 ; 2015; Journal Autoimmunity; vol. 48; no. 5; pp. 344-51; doi:10.3109/08916934.2015.1008464
Robust Intensity Standardization in Brain Magnetic Resonance Images.
De Nunzio G, Cataldo R, Carla A.
2015; Journal Journal of Digital Imaging; pp. 1-11;
Soluble BACE-1 Activity and sAβPPβ Concentrations in Alzheimer's Disease and Age-Matched Healthy Control Cerebrospinal Fluid from the Alzheimer's Disease Neuroimaging Initiative-1 Baseline Cohort
Savage, M. J., Holder, D. J., Wu, G. X., Kaplow, J., Siuciak, J. A., & Potter, W. Z.
PMID: 25790831 ; 2015; Journal Journal of Alzheimer's Disease; vol. 46; no. 2; pp. 431-440; doi:10.3233/JAD-142778